ALLO
Allogene Therapeutics Inc.
Company Overview
| Mkt Cap | $253.73M | Price | $1.20 |
| Volume | 1.62M | Change | -3.63% |
| P/E Ratio | -1.0 | Open | $1.25 |
| Revenue | $22.0K | Prev Close | $1.24 |
| Net Income | $-257.6M | 52W Range | $0.86 - $3.78 |
| Div Yield | N/A | Target | $7.56 |
| Overall | 38 | Value | 60 |
| Quality | 28 | Technical | 27 |
No chart data available
Stock Overview
Updated DailyAllogene Therapeutics Inc. (ALLO) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.24 with a market capitalization of $253.73 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ALLO with a volume of 1.65 million shares. The stock opened up 3.31% from yesterday's close of $1.21. Current analyst estimates project earnings of $-0.98 per share for this year, with next year targeting $-0.87.
ALLO demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ALLO include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 509.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALLO | $1.20 | -3.6% | 1.62M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Allogene Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW